Project Leader
 | DAVID WISHART is a Professor in the Departments of Computing Science and Biological Sciences, and in the Faculty of Pharmacy at the University of Alberta. In 2003 he was cross-appointed as Director of Nanobiology and Senior Research Officer at the NRC's National Institute for Nanotechnology (NINT). He has co-founded two companies (Chenomx and BioTools) and serves as the Chief Scientific Officer for both. He is also the Director of the PENCE and Alberta Cancer Board bioinformatics core facilities, and the Director of the Canadian Bioinformatics Help Desk. Dr. Wishart held the CIHR Bristol-Myers Squibb chair in protein chemistry. He has won several awards including the AAAS young investigator prize and the Astra-Zeneca young investigator prize. Since 1990 Dr. Wishart has published more than 120 papers and book chapters, and presented more than 100 abstracts at scientific conferences. His discoveries concerning NMR chemical shifts in the early 1990's made him one of the most cited Canadian scientists of the past decade. Dr. Wishart will act as the project's Principal Investigator and will be active in characterizing the human metabolome via NMR, and in designing and testing key software. He will also be responsible for integrating the NMR, MS and microfluidics research projects and in working with clinical collaborators based at the University of Alberta and at the University of Calgary. |
